TPS Treatment for Autism
Transcranial Pulse Stimulation (TPS) – Indication: Autism
Autism or Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by a wide variation in social skills, communication and behaviour. The symptoms and severity can vary greatly, which is why the term “spectrum” is used. Typical characteristics of autism are difficulties in social interaction, restricted and repetitive behavior patterns as well as special interests or occupations. In particular, communication skills are often affected: Some people with autism are unable to speak or speak very little, while others are very articulate but have difficulty adapting in conversations or understanding sarcasm and metaphors. The prevalence of autism has increased significantly in recent decades, partly due to improved diagnosis and greater awareness. Worldwide, it is estimated that about one percent of the population is affected by the autism spectrum. In the USA, according to the Centers for Disease Control and Prevention (CDC), around one in 36 children aged eight are affected by autism. In Europe, the estimated prevalence rate is also around one percent. Treatment for autism has so far focused on early intervention, behavioral therapy and other educational approaches to improve social and communication skills. Medication can be used to treat specific symptoms or comorbidities such as anxiety or ADHD. Because autism spans a broad spectrum, treatment requires an individualized approach that addresses the specific needs of the individual.
TPS Treatment for Autism: Goals and possibilities of TPS therapy
As with ADHD, the neuromodulation procedure Transcranial Pulse Stimulation (TPS) is used in case studies and clinical research. The results show significant interactions in the “Childhood Autism Rating Scale” and other secondary results, also with regard to possible placebo effects. As TPS can also be used effectively and safely for patients in this indication, those affected can already be treated with TPS as part of “off-label” therapy in individual cases (see also: Clinical study investigates TPS in autism ).
